{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:28:57Z","timestamp":1783042137470,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ejso.2016.09.021","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T20:02:55Z","timestamp":1479499375000},"page":"401-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Isolated limb perfusion for the management limb threatening soft tissue sarcomas: The role of histological type on clinical outcomes"],"prefix":"10.1016","volume":"43","author":[{"given":"M.","family":"Rastrelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mocellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Stramare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Brunello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maruzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Scarzello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Buzzaccarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pilati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Saadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"Del Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2790-2747","authenticated-orcid":false,"given":"A.","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Montesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.G.","family":"Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tropea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.R.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2016.09.021_bib1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3322\/canjclin.54.2.94","article-title":"Soft tissue sarcoma","volume":"54","author":"Cormier","year":"2004","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.ejso.2016.09.021_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000658-198209000-00009","article-title":"The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb sparring surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy","volume":"196","author":"Rosenberg","year":"1982","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2016.09.021_bib3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00000658-200203000-00015","article-title":"Analysis of the prognostic significance of microscopic margins in 2084 localized primary adult soft tissue sarcomas","volume":"235","author":"Stojadinovic","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2016.09.021_bib4","first-page":"269","article-title":"Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity","volume":"3","author":"Williand","year":"1992","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2016.09.021_bib5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00000658-195810000-00009","article-title":"Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit","volume":"148","author":"Creech","year":"1958","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2016.09.021_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cytogfr.2004.11.001","article-title":"Tumor necrosis factor, cancer and anticancer therapy","volume":"16","author":"Mocellin","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ejso.2016.09.021_bib7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3892\/or.3.6.1059","article-title":"TNF-alpha and doxorubicin in hypertermic perfusion for limb sarcoma","volume":"3","author":"Rossi","year":"1996","journal-title":"Oncol Rep"},{"issue":"7","key":"10.1016\/j.ejso.2016.09.021_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/annonc\/mdi229","article-title":"Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better?","volume":"16","author":"Bonvalot","year":"2005","journal-title":"Ann Oncol"},{"issue":"17","key":"10.1016\/j.ejso.2016.09.021_bib9","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1002\/cncr.29991","article-title":"Role of isolated limb perfusion with recombinant human tumor necrosis factor \u03b1 and melphalan in locally advanced extremity soft tissue sarcoma","volume":"1","author":"Jakob","year":"2016","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2016.09.021_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ctrv.2012.10.005","article-title":"Isolated limb perfusion of soft tissue sarcomas: a comprehensive review of literature","volume":"39","author":"Seinen","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.ejso.2016.09.021_bib11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/ncponc0426","article-title":"Technology insight: utility of TNF-alpha-based isolated limb perfusion to avoid amputation of irresectable tumors of the extremities","volume":"3","author":"Gr\u00fcnhagen","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2016.09.021_bib12","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1742::AID-CNCR16>3.0.CO;2-G","article-title":"Soft tissue limb sarcomas: Italian clinical trials with hyperthermic antiblastic perfusion","volume":"86","author":"Rossi","year":"1999","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2016.09.021_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/02656736.2015.1101170","article-title":"Hyperthermic isolated limb perfusion in locally advanced limb soft tissue sarcoma: a 24-year single-centre experience","volume":"32","author":"Rastrelli","year":"2016","journal-title":"Int J Hyperth"},{"issue":"12","key":"10.1016\/j.ejso.2016.09.021_bib14","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1245\/s10434-009-0733-9","article-title":"Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient","volume":"16","author":"Bonvalot","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"6\u20137","key":"10.1016\/j.ejso.2016.09.021_bib15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.canrad.2006.05.015","article-title":"Function preserving surgery of limb sarcomas: history and improvements","volume":"10","author":"Bonvalot","year":"2006","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ejso.2016.09.021_bib16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00000658-199612000-00011","article-title":"Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience","volume":"224","author":"Eggermont","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2016.09.021_bib17","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1200\/JCO.2011.35.6618","article-title":"Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas","volume":"29","author":"Deroose","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2016.09.021_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10434-000-0155-1","article-title":"Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations","volume":"7","author":"Issakov","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2016.09.021_bib19","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/1097-0142(19940415)73:8<2140::AID-CNCR2820730819>3.0.CO;2-0","article-title":"Phase II study on neoadjuvant hypertermic antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas","volume":"73","author":"Rossi","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2016.09.021_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00006231-200401000-00009","article-title":"Optimized procedure of real-time sistemic leakage monitoring during isolated limb perfusion using a hand held gamma probe and 99m Tc-HSA","volume":"25","author":"Casara","year":"2004","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejso.2016.09.021_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(03)01141-0","article-title":"Current uses of isolated limb perfusion in the clinic and a model system for new strategies","volume":"4","author":"Eggermont","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2016.09.021_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00002371-200307000-00001","article-title":"TNF alpha-based isolated perfusion for limb-threatening soft tissue sarcomas: state of the art and future trend","volume":"26","author":"Rossi","year":"2003","journal-title":"J\u00a0Immunother"},{"key":"10.1016\/j.ejso.2016.09.021_bib23","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/jso.21885","article-title":"TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long-term patient outcome","volume":"103","author":"Hoven-Gondrie","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2016.09.021_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/02656730701868387","article-title":"Effectiveness of regional chemotherapy with TNF-alpha\/melphalan in advanced soft tissue sarcoma of the extremities","volume":"24","author":"Taeger","year":"2008","journal-title":"Int J Hyperth"},{"key":"10.1016\/j.ejso.2016.09.021_bib25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jso.22121","article-title":"Isolated limb perfusion with TNF-\u03b1lpha and melphalan for distal part of the limb in soft tissue sarcoma patients","volume":"105","author":"Deroose","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2016.09.021_bib26","first-page":"363","article-title":"Hypertermic isolated perfusion with tumor necrosis factor-\u03b1lpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of Italian Society of Integrated Locoregional Treatment in Oncology","volume":"23","author":"Di Filippo","year":"2009","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.ejso.2016.09.021_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejso.2012.12.018","article-title":"Outcomes of isolated limb perfusion in the treatment of extremity soft tissue sarcoma: a systematic review","volume":"39","author":"Bhangu","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2016.09.021_bib28","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.2353\/ajpath.2010.100104","article-title":"Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics","volume":"177","author":"P\u00e9rot","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejso.2016.09.021_bib29","doi-asserted-by":"crossref","first-page":"e38808","DOI":"10.1371\/journal.pone.0038808","article-title":"Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-\u03b1 by restoring p53 function","volume":"7","author":"Muret","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejso.2016.09.021_bib30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jso.21724","article-title":"Tumor vascularization and histopathologic regression of soft tissue sarcomas treated with isolated limb perfusion with TNF-\u03b1 and melphalan","volume":"103","author":"Grabellus","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2016.09.021_bib31","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/cncr.11648","article-title":"Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities","volume":"98","author":"Noorda","year":"2003","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ejso.2016.09.021_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.21802","article-title":"Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusion with tumor necrosis factor-\u03b1 and melphalan for limb-threatening soft tissue sarcoma","volume":"106","author":"Grunhagen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2016.09.021_bib33","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1245\/s10434-006-9323-2","article-title":"Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: three time periods at risk for amputation","volume":"14","author":"Van Ginkel","year":"2007","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316309532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316309532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T04:23:18Z","timestamp":1657772598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798316309532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0748798316309532"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2016.09.021","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isolated limb perfusion for the management limb threatening soft tissue sarcomas: The role of histological type on clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2016.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}